Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Meningococcal disease
NITAG documentation
2015
Clear all
Type of publications
NITAG documentation
(9)
SAGE documentation
(5)
Scientific publications
(2)
Systematic reviews (SYSVAC)
(3)
Topics
Background paper
(3)
Recommendation
(6)
Regions
Americas
(5)
Europe
(4)
Countries
Canada
(1)
France
(1)
Germany
(1)
Switzerland
(2)
United States of America
(4)
Diseases
Meningococcal disease
(9)
Diphtheria
(1)
Haemophilus influenzae type B
(3)
Hepatitis A
(4)
Hepatitis B
(3)
Human papillomavirus (HPV)
(15)
Influenza
(14)
Measles
(3)
Pertussis
(4)
Pneumococcal disease
(5)
Poliomyelitis
(1)
Rotavirus
(2)
Typhoid
(1)
Yellow fever
(4)
Publication date
2015
(9)
2024
(1)
2023
(23)
2022
(74)
2021
(164)
2020
(83)
2019
(13)
2018
(12)
2017
(4)
2016
(12)
2014
(13)
2013
(5)
2011
(4)
2010
(5)
2009
(2)
2008
(1)
2007
(2)
2006
(5)
2005
(1)
2001
(1)
2000
(1)
1997
(1)
Target population
Available to download in languages
English (EN)
(6)
French (FR)
(3)
9 results found
2015
∙
STIKO
Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal disease
2015
∙
ACIP
Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) for Use of Serogroup B Meningococcal (MenB) Vaccines in Adolescents and Young Adults (Including College Students)
2015
∙
NACI
Update on Quadrivalent Meningococcal Vaccines available in Canada
2015
∙
Jessica MacNeil
Considerations for Use of Serogroup B Meningococcal (MenB) Vaccines in Persons at Increased Risk
2015
∙
Haut Conseil de la santé publique
Notice relating to the immunisation recommendations against invasive meningococcal C infections after 24 years, notably in men who have sex with other men (MSM)
2015
∙
CFV
Prévention des infections graves dans les asplénies anatomiques ou fonctionnelles
2015
∙
CFV
Recommandations de vaccination contre les méningo- coques pour les personnes à risque accru d’infection invasive et d’exposition : utilisation d’un vaccin quadri- valent conjugué également lors de rappels
2015
Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults
2015
∙
Temitope Folaranmi, Lorry Rubin, Stacey W. Martin, Manisha Patel, Jessica MacNeil
Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register